Patricia Rangel | Boehringer Ingelheim Careers Patricia Rangel | Boehringer Ingelheim Careers "Patricia Rangel of Corporate Strategy & Consulting describes Boehringer Ingelheim as a family company that operates with the highest integrity standards."
Christian Betz Christian Betz Christian Betz shares his experience leading the process engineering team at Boehringer Ingelheim site in Biberach, Germany.
Ann-Kathrin Koller Ann-Kathrin Koller Career choices, culture, the future and more with Ann-Kathrin Koller.
Stefanie Bock Kreilinger Stefanie Bock Kreilinger Stefanie Bock-Kreilinger works in the legal department at Boehringer Ingelheim as head of corporate legal medicine, evidence and digital health.
Daniel Kiesenhofer Daniel Kiesenhofer Daniel Kiesenhofer talks about his role as Project Manager Quality Control at Boehringer Ingelheim in Vienna, Austria.
Anna Mistrioti Anna Mistrioti Anna Mistrioti speaks about working as a Quality Control Compliance Officer in Boehringer Ingelheim, in the Koropi Plant of Greece.
Edda Dankmeyer Edda Dankmeyer Edda Dankmeyer leads Sustainable Development Communications and explains how sustainable development can bea key differentiator for the company.
Corporate Compliance Program Corporate Compliance Program Our E&C Program conforms with the principles and recommendations published in guides from various Federal agencies and industry related organizations
Company History | Corporate Profile | Boehringer Ingelheim US Company History | Corporate Profile | Boehringer Ingelheim US Click here to watch our video on the history of Boehringer Ingelheim, founded by Albert Boehringer in 1885.
Where To Meet Us | Animal Health | Boehringer Ingelheim US Where To Meet Us | Animal Health | Boehringer Ingelheim US Click here to find out which pharmaceutical events Boehringer Ingelheim are attending over the next year and where you can get in touch with us.
Contact Our Team | Human Health | Boehringer Ingelheim US Contact Our Team | Human Health | Boehringer Ingelheim US Find all our contact information here as well as the latest updates on where you can meet our partnering teams virtually or in person.
Anna Mezentseva Anna Mezentseva Anna Mezentseva talks about being a discovery management trainee in Finance and Controlling.
Jan-Erik Schafer Jan-Erik Schafer Jan Erik, Senior Team Leader in the upstream pharmaceutical production talks about his motivating and fun career at Boehringer Ingelheim.
Ryan Henri Rickards Ryan Henri Rickards Ryan Henry Rickards, a senior finance manager for US Animal Health Commercial Controlling team, highlights his career at Boehringer Ingelheim.
Boehringer welcomes 2023 Gold Report Boehringer welcomes 2023 Gold Report Boehringer welcomes 2023 GOLD Report Positioning LAMA/LABA as preferred treatment
Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm) Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm) Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm)
Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD Phase III study showed Ofev slows the loss of pulmonary function in people living with systemic sclerosis associated ILD
How Much Do You Know About PPID? | Boehringer Ingelheim US How Much Do You Know About PPID? | Boehringer Ingelheim US Click here to find out more about some of the common misconceptions you might have about pituitary pars intermedia dysfunction (PPID).
Vikas joined from hospital sector Vikas joined from hospital sector Are you considering moving into pharmaceuticals for the first time? Vikas made the leap and has never looked back.
FDA approves the first treatment option for generalized pustular psoriasis flares in adults FDA approves the first treatment option for generalized pustular psoriasis flares in adults FDA approves the first treatment option for generalized pustular psoriasis flares in adults